Marc K Hellerstein

发表

Emerging applications of kinetic biomarkers in preclinical and clinical drug development.

Scott M Turner, Marc K Hellerstein, S. Turner, 2005, Current opinion in drug discovery & development.

Discovery of Novel Hippocampal Neurogenic Agents by Using an in Vivo Stable Isotope Labeling Technique

Robert Busch, Marc K Hellerstein, Chelsea King, 2006, Journal of Pharmacology and Experimental Therapeutics.

Cycle Regulation in Islets with Diabetes Susceptibility a Gene Expression Network Model of Type 2 Diabetes Links Cell P

Eric E Schadt, Ping Wang, Christina Kendziorski, 2008 .

Isolation of malignant B cells from patients with chronic lymphocytic leukemia (CLL) for analysis of cell proliferation: validation of a simplified method suitable for multi-center clinical studies.

Robert Busch, Marc K Hellerstein, N. Chiorazzi, 2010, Leukemia research.

Exploiting Complexity and the Robustness of Network Architecture for Drug Discovery

Marc K Hellerstein, M. Hellerstein, 2008, Journal of Pharmacology and Experimental Therapeutics.

Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.

Wei Zhang, Marc K Hellerstein, R. Krauss, 2009, The Journal of clinical investigation.

Measurement of brain microglial proliferation rates in vivo in response to neuroinflammatory stimuli: Application to drug discovery

Mohamad Awada, Robert Busch, Marc K Hellerstein, 2007, Journal of neuroscience research.

New stable isotope-mass spectrometric techniques for measuring fluxes through intact metabolic pathways in mammalian systems: introduction of moving pictures into functional genomics and biochemical phenotyping.

Marc K Hellerstein, M. Hellerstein, 2004, Metabolic engineering.

Isolation of peripheral blood CD4(+) T cells using RosetteSep and MACS for studies of DNA turnover by deuterium labeling.

Robert Busch, Marc K Hellerstein, J. McCune, 2004, Journal of immunological methods.

In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells.

Marc K Hellerstein, N. Chiorazzi, S. Zupo, 2005, The Journal of clinical investigation.

Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib.

Naveen Garg, Dominik Wodarz, Xuelin Huang, 2017, JCI insight.

Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection.

Marc K Hellerstein, J. McCune, M. Hellerstein, 2003, The Journal of clinical investigation.

In vivo measurement of fluxes through metabolic pathways: the missing link in functional genomics and pharmaceutical research.

Marc K Hellerstein, M. Hellerstein, 2003, Annual review of nutrition.

Stable isotope-mass spectrometric measurements of molecular fluxes in vivo: emerging applications in drug development.

Marc K Hellerstein, M. Hellerstein, E. Murphy, 2004, Current opinion in molecular therapeutics.

Alternate-day fasting and chronic disease prevention: a review of human and animal trials.

Marc K Hellerstein, M. Hellerstein, K. Varady, 2007, The American journal of clinical nutrition.

A critique of the molecular target-based drug discovery paradigm based on principles of metabolic control: advantages of pathway-based discovery.

Marc K Hellerstein, M. Hellerstein, 2008, Metabolic engineering.